261101 Assessment of studies of health outcomes related to the recommended childhood immunization schedule

Wednesday, October 31, 2012 : 8:50 AM - 9:10 AM

Karen Helsing, MHS , Institute of Medicine of the National Academies, Washington, DC
Suzanne Landi , Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies, Washington, DC
Background: As the number of routinely recommended vaccines has increased, the routine childhood immunization schedule has become increasingly crowded and complex with both an increased number of vaccine visits and often an increased number of vaccines administered during these visits. In addition to this complexity of vaccine delivery, some parents, other members of the public, and advocacy groups have raised questions about the potential adverse health outcomes that may be a consequence of simultaneous or sequential administration of recommended childhood vaccines, the timing and/or co-administration of vaccines, and the recommended childhood immunization schedule overall. Methods: In response to a request from the National Vaccine Program Office (NVPO), the IOM convened a committee of experts to conduct an independent assessment surrounding the feasibility of -- and issues surrounding -- studying children who may receive or have received different immunization in order to determine if it is possible to detect differences in health outcomes between these groups that can be attributed to the vaccine schedule. The committee is asked to: review scientific findings and stakeholder concerns related to the safety of the recommended childhood immunization schedule; identify potential research approaches, methodologies, and study designs that could inform this question, including an assessment of the potential strengths and limitations of each approach, methodology and design, as well as the financial and ethical feasibility of doing them and; issue a report summarizing their findings. Results & Conclusions: The report, which the speaker will discuss, is expected to be publicly released in October 2012.

Learning Areas:
Epidemiology
Ethics, professional and legal requirements
Public health or related research

Learning Objectives:
Assess feasible approaches to studying children who may receive or have received different immunization in order to determine if it is possible to detect differences in health outcomes between these groups that can be attributed to the vaccine schedule as outlined in the recommendations of the IOM Committee on the Assessment of Studies of Health Outcomes Related to the Recommended Childhood Immunization Schedule. Explain the complexities (ethical, methodological, financial) regarding examining the childhood immunization schedule

Keywords: IOM, Immunizations

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am a Research Associate at the Institute of Medicine and have worked on this study for the past year. My supervisor is Karen Helsing, the original presenting author.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.